Clinical Trials Browser

Phase 1 × Terminated × CTL019 chimeric antigen receptor × Clear all

NCT01551043 2020-07-09

Allo CART-19 Protocol

Phase 1 Terminated

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma